Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
The glucocorticoid receptor (GR) is an important anti-cancer target in lymphoid cancers but has been understudied in solid tumors like lung cancer, although glucocorticoids are often given with chemotherapy regimens to mitigate side effects.Here, we identify a dexamethasone-GR mediated anti-cancer response in a subset of aggressive non-small cell l